mAb process intensification: Wei Gong, Henlius Biotech
Wei Gong, Director at Henlius Biotech, Shanghai shares key insights on implementing continuous bioprocessing in mAb manufacturing. She works with process development for downstream processes. In this video, you will get her views on the main opportunities and challenges for the industry.
2020年3月27日 | 00:03:29
Mute
Current Time 0:00
/
Duration Time 0:00
Loaded: 0%
Progress: 0%
Stream TypeLIVE
Remaining Time -0:00
Playback Rate
1
Chapters
Chapters
descriptions off, selected
Descriptions
subtitles off, selected
Subtitles
captions settings, opens captions settings dialog
captions off, selected
Captions
Audio Track
This is a modal window.
No compatible source was found for this media.
Caption Settings Dialog
Beginning of dialog window. Escape will cancel and close the window.
mAb process intensification: Wei Gong, Henli...00:03:29
Scaling up viral vector manufacturing: Carol...00:03:34
Smarter and smaller biomanufacturing: Günter...00:04:18
Emerging technologies in biomanufacturing: L...00:03:35
Cell and gene therapy manufacturing: Catarin...00:04:00
Distribution of cell and gene therapies: Cat...00:02:54
Visions for the digitalization of biomanufac...00:02:58
持续增强信心
您如何为 GMP 生物生产实施连续性战略?在本案例研究中,上海复宏汉霖生物技术股份有限公司董事 Wei Gong 博士分享了一些有显著意义的成果,这些成果代表了在生产力和设施占地面积方面取得的进步。她还提出了他们在此过程中面临的一些挑战。